A Double Blind Randomised Comparison of Vorapaxar Versus Placebo for the Treatment of HIV Associated Inflammation and Coagulopathy in Patients With Well Controlled HIV Replication
Phase of Trial: Phase I/II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Vorapaxar (Primary)
- Indications Blood coagulation disorders; Inflammation
- Focus Therapeutic Use
- Acronyms ADVICE
- 20 Jun 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 20 Jun 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated